Abstract:Abstract Introduction: Pan-histone deacetylase (HDAC) inhibitors have been used as anti-cancer agents due to their cytotoxicity. However, studies from our group have reported that intervention of class-specific HDAC inhibitors can differentially affect immune-related pathways in macrophages and influence their pro- or anti-inflammatory phenotype and function. For example, specific HDAC6 inhibitors demonstrated promising anti-tumor effects by suppressing tumor-promoting M2 macrophages in the tumor microenvironment (TME). In contrast, inhibition of HDAC11 promoted the anti-inflammatory phenotype of macrophages. Besides the divergent roles and distinct signaling pathways, a comprehensive study on the effect of HDCA6 and HDAC11 inhibition on macrophage phenotype and the implications on TME and inflammation is warranted. Objective: To determine the effect of HDAC6 and HDAC11 inhibition on the phenotype and function of macrophages in the context of the TME. Methods: Bone marrow-derived macrophages (BMDMs) isolated from C57BL/6 mice were pre-treated with HDAC6 (NexturastatA) or HDAC11 (FT895) inhibitors prior to polarizing them to M1 and M2 phenotypes. Similarly, BMDMs were isolated from total knockouts (KO) of HDAC6 and HDAC11 mice. The changes in gene expression were identified by RNA-seq analysis. Furthermore, single-cell secretome analysis on Isoplexis platform was performed from human and mice BMDMs on a panel of cytokines and chemokines. Results: Transcriptomic analysis revealed that HDAC6 inhibition in M1 polarized BMDMs sustained inflammatory gene signature while suppressing the tumor-promoting and anti-inflammatory genes in M2 macrophages. This supported our previous reports where HDAC6i increased M1/M2 ratio in murine melanoma models. In contrast, HDAC11 inhibition in M2 macrophages upregulated classical M2 markers, whereas M1-associated gene signature was minimally affected. These results were recapitulated in HDAC6KO and HDAC11KO macrophages, suggesting a high specificity of the inhibitors. Further validation at protein level by single-cell secretome analysis indicated that HDAC11 inhibition in M2 polarized BMDMs increased secretion of growth factors such as Egf and Pdgf and of anti-inflammatory cytokines such as Il10 and Il13. On the contrary, HDAC6 inhibition upregulated inflammatory cytokines such as Ifng and Tnf and T-cell recruiting chemokine Cxcl10 in the M1 phenotype. Conclusions:Transcriptomics and single-cell secretome analyses of macrophages indicate that HDAC6 and HDAC11 affects macrophage function in diametrically opposite directions. Therefore, our study underscores the importance of class-selective inhibition of HDACs over pan-HDAC inhibitors and the potential use of selective HDAC inhibitors as a therapeutic option to control macrophage phenotype in cancer and other conditions. Citation Format: Manasa Suresh, Hawa Coulibaly, Xintang Li, David Quiceno-Torres, Nithya Gajendran, Karen Tan, Matias Hepp, Karthik Musunuri, Satish Noonepalle, Alejandro Villagra. Inhibition of HDAC6 and HDAC11 has opposite effects on inflammation and the modulation of the functional phenotype of macrophages in the tumor microenvironment [abstract]. In: Proceedings of the American Association for Cancer Research Annual Meeting 2023; Part 1 (Regular and Invited Abstracts); 2023 Apr 14-19; Orlando, FL. Philadelphia (PA): AACR; Cancer Res 2023;83(7_Suppl):Abstract nr 2880.

Impact of HDAC inhibitors on macrophage polarization to enhance innate immunity against infections

Classical HDACs in the Regulation of Neuroinflammation.

HDAC3 Mediates the Inflammatory Response and LPS Tolerance in Human Monocytes and Macrophages

Histone Deacetylases (HDACs) Roles in Inflammation-mediated Diseases; Current Knowledge

Epigenetic regulation in bacterial infections: targeting histone deacetylases

HDACi: molecular mechanisms and therapeutic implications in the innate immune system

Histone Deacetylase Isoforms Regulate Innate Immune Responses by Deacetylating Mitogen-Activated Protein Kinase Phosphatase-1.

HDAC7 is an immunometabolic switch triaging danger signals for engagement of antimicrobial versus inflammatory responses in macrophages

Abstract 2880: Inhibition of HDAC6 and HDAC11 has opposite effects on inflammation and the modulation of the functional phenotype of macrophages in the tumor microenvironment

Deacetylation of Histones and Non-histone Proteins in Inflammatory Diseases and Cancer Therapeutic Potential of Histone Deacetylase Inhibitors

Histone Deacetylase Inhibitors Directly Modulate T Cell Gene Expression and Signaling and Promote Development of Effector-Exhausted T Cells in Murine Tumors

Hdac6 Deacetylase Activity Is Critical For Lipopolysaccharide-Induced Activation Of Macrophages

The HDAC10 instructs macrophage M2 program via deacetylation of STAT3 and promotes allergic airway inflammation

Unlocking Macrophage Secrets: Histone Deacetylases in Chronic Transplant Rejection

Degradation of HDAC10 by autophagy promotes IRF3-mediated antiviral innate immune responses

Efficacy of HDAC Inhibitors in Driving Peroxisomal β-Oxidation and Immune Responses in Human Macrophages: Implications for Neuroinflammatory Disorders

Epigenetic control of macrophage polarization

Dietary Inhibitors of Histone Deacetylases in Intestinal Immunity and Homeostasis

HDAC Inhibition Potentiates Anti-Tumor Activity of Macrophages and Enhances Anti-Pd-l1-mediated Tumor Suppression

HDAC6 Mediates Poly (I:C)-Induced TBK1 and Akt Phosphorylation in Macrophages

Histone deacetylase inhibition by sodium valproate regulates polarization of macrophage subsets.